AKT1 and glucose metabolism disease: NPY may affect glucose metabolism by modulating the phosphorylation of PI3K, AKT and GSK3 in adipose tissue and adipocytes, and it is possible that the NPY Y5 receptor contributes to glucose metabolism disorder induced by NPY.